Menu

Prometheus Biosciences, Inc. RXDX

Full chart Compare
Set alert

Price alert · RXDX

All alert types
199.92 +199.92

Day range unavailable

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $4.03MExpenses → Selling, General & Admin: $39.74MExpenses → Research & Development: $112.85MGross Profit → Expenses: $6.81MRevenue → Gross Profit: $6.81MNet Loss → Expenses: $141.75MOther Income$4.03MGross Profit$6.81MNet Loss$141.75MExpenses$152.59MSelling, General & Admin$39.74MResearch & Development$112.85MRevenue$6.81M

Latest period ending Dec 31, 2022 · select a line to chart its full history

Annual income statement

RXDX annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
6.81M3.13M1.23M1.12M
6.81M3.13M1.23M1.12M
6.81M3.13M1.23M1.12M
152.59M90.93M30.24M17.09M
112.85M62.43M19.15M10.96M
39.74M28.50M11.09M6.13M
-145.78M-87.80M-29.01M-15.97M
-141.75M-90.19M-37.14M-29.72M
-141.75M-90.19M-37.14M-29.72M
-141.75M-90.19M-37.14M-29.72M
-141.75M-90.19M-37.14M-29.72M
-3.49-2.88-24.78-26.47
-3.49-2.88-24.78-26.47
-3.49-2.88-24.78-26.47
-141.75M-89.33M-35.01M-28.95M
-141.75M-89.33M-35.01M-28.95M
40.62M31.33M1.50M1.12M
40.62M31.33M1.50M1.12M